Fidock D A, Nomura T, Talley A K, Cooper R A, Dzekunov S M, Ferdig M T, Ursos L M, Sidhu A B, Naudé B, Deitsch K W, Su X Z, Wootton J C, Roepe P D, Wellems T E
National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.
Mol Cell. 2000 Oct;6(4):861-71. doi: 10.1016/s1097-2765(05)00077-8.
The determinant of verapamil-reversible chloroquine resistance (CQR) in a Plasmodium falciparum genetic cross maps to a 36 kb segment of chromosome 7. This segment harbors a 13-exon gene, pfcrt, having point mutations that associate completely with CQR in parasite lines from Asia, Africa, and South America. These data, transfection results, and selection of a CQR line harboring a novel K761 mutation point to a central role for the PfCRT protein in CQR. This transmembrane protein localizes to the parasite digestive vacuole (DV), the site of CQ action, where increased compartment acidification associates with PfCRT point mutations. Mutations in PfCRT may result in altered chloroquine flux or reduced drug binding to hematin through an effect on DV pH.
恶性疟原虫遗传杂交中维拉帕米可逆性氯喹抗性(CQR)的决定因素定位于7号染色体上一个36 kb的片段。该片段包含一个有13个外显子的基因pfcrt,其点突变与来自亚洲、非洲和南美洲的寄生虫株中的CQR完全相关。这些数据、转染结果以及对携带新型K761突变的CQR株的选择表明PfCRT蛋白在CQR中起核心作用。这种跨膜蛋白定位于寄生虫消化液泡(DV),即氯喹作用的部位,在那里隔室酸化增加与PfCRT点突变相关。PfCRT中的突变可能通过影响DV pH值导致氯喹通量改变或药物与血红素的结合减少。